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Previews(Figure 1D), the host upregulates anti-
stress circuits that counterbalance allo-
static systems, e.g., the anti-inflammatory
cholinergic and glucocorticoid pathways.
Prolonged activation of these adaptive
systems ultimately becomes maladap-
tive, leading to immunosuppression and
increased susceptibility to infectious dis-
eases, a model that is further substanti-
ated here by Radek et al. (2010).
Significantly, this paper demonstrates
the specific means and receptor types
by which the cholinergic systems regulate
cathelicidin production in the skin. This
opens many new avenues for therapeutic
intervention in inflammatory and infec-
tious conditions triggered by states of
chronic stress. For example, overproduc-
tion of cathelicidins implicated in psori-
asis could be attenuated by the topical
application of a designer nicotinic agonist;
whereas, conversely, underproduction of
cathelicidins could be reversed by topical
applications of cathelicidins (or other hostpeptides) or by designer nicotinic antago-
nists as part of anti-infective strategies.
Clinical trials of known inducers of host
defense peptides (vitamin D and sodium
butyrate) in the context of infection are
already underway, and thus proof of prin-
ciple of this approach is already being
established. In the world of increasing
global resistance to conventional antimi-
crobial agents and increasing preva-
lence of auto-inflammatory conditions,
this type of ‘‘thinking outside the box’’
will become increasingly critical in the
prophylaxis and treatment of human
infectious and inflammatory diseases.REFERENCES
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As part of innate immune signaling, plants employ a suite of receptors, kinases, and resistance proteins
to recognize pathogen-derived effector proteins. In this issue of Cell Host & Microbe, Zhang et al. provide
evidence refining the link between multiple layers of defense signaling in response to bacterial pathogen
infection.Recent studies have highlighted the
molecular-genetic arms race between
the plant immune system and pathogen
virulence effectors (reviewed in Chisholm
et al., 2006 and Jones and Dangl, 2006).
In particular, pathogen effectors often
target the plant immune response net-
work (Boller and He, 2009), and in return,
plants refine and expand their immune
system to defend against pathogens. In
this issue of Cell Host & Microbe, Zhang
et al. (2010), present evidence that severalrelated Arabidopsis cytoplasmic receptor
kinases, exemplified by botrytis-induced
kinase 1 (BIK1) (Veronese et al., 2006)
and AvrPphB susceptible (PBS1) (Shao
et al., 2003), are cleaved by AvrPphB, a
cysteine protease effector from the phy-
topathogenic bacterium Pseudomonas
syringae. BIK1 turns out to be particularly
important for plant immune responses,
illustrating an excellent example of the
utility of pathogen effectors as molecular
probes in identifying new components ofthe plant immune system. This work also
provides new insights as to how plants
recognize the virulence action of AvrPphB
and use it against bacterial infection.
Innate immune signaling in plants is
initiated as a consequence of the recog-
nition of specific pathogen-associated
molecular patterns (PAMP) by cognate
plasma membrane-localized pathogen
recognition receptors (PRRs). Collectively
referred to as PAMP-triggered immunity
(PTI) (Chisholm et al., 2006; Jones ande 7, April 22, 2010 ª2010 Elsevier Inc. 259
Figure 1. Model for the Molecular Link between PTI and ETI via the Action of the Cysteine Protease Effector AvrPphB
(A) In the presence of a nonpathogenic bacterium, such as a T3SSmutant, perception of PAMPs triggers PTI through pattern recognition receptors resident in the
plasmamembrane of the plant cell; these include the chitin oligosaccharide receptor, CERK1; the EF-Tu receptor, EFR; and the flagellin receptor, FLS2. Signaling
mediated by these receptors requires the presence of associated signaling partners such as BAK1 (not shown) and BIK1, as well as some PBL kinases.
(B) In a plant cell infected by a virulent pathogen, such as Pseudomonas syringae, bacteria deliver effector proteins through the T3SS to suppress PTI. In the case
of the effector AvrPphB, inactivation of PTI is achieved via the catalytic action of AvrPphB on BIK1, PBS1, and PBL kinases. If the plant cell has the resistance
protein RPS5, cleavage of the kinase PBS1 is sensed by RPS5, resulting in the activation of ETI. T3SS, type III secretion system; PAMP, pathogen-associated
molecular patterns; PTI, PAMP-triggered immunity; ETI; effector-triggered immunity; RPS5, resistance to Pseudomonas syringae protein 5; PBL, PBS1-like.
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PreviewsDangl, 2006), this ‘‘layer’’ of host defense
signaling is analogous to Toll-like re-
ceptor-mediated immune signaling in
mammals and represents the first line of
resistance activated in defense against
pathogen infection. Following the recog-
nition of pathogen effector molecules or
their activities by plant disease resistance
(R) proteins, effector-triggered immunity
(Chisholm et al., 2006; Jones and Dangl,
2006) results in both the amplification
of PTI, as well as the specialization of
defense signaling, and constitutes the
second layer of defense. Recent work
has provided evidence that PTI and ETI
share common signaling networks and
are connected via the action of pathogen
effectors. In the current work, Zhang et al.
present data that illustrate how the
activity of AvrPphB links these connec-
tions.
Previous work has shown that, in
certain Arabidopsis accessions, after
delivery into the host cell via the bacterial
type III secretion system, AvrPphB is
recognized by the cytoplasmic R protein
RPS5, resulting in the activation of ETI
(Shao et al., 2003). As shown in Figure 1,
the activation of RPS5-mediated resis-
tance requires the catalytic activity of
AvrPphB, which until now, was thought
to cleave a single kinase, PBS1, in Arabi-
dopsis (Shao et al., 2003). Following
cleavage of PBS1 by AvrPphB, it is
thought that release of PBS1 from RPS5
induces a conformational change in RPS5
(and/or associated resistance complex),260 Cell Host & Microbe 7, April 22, 2010 ª2resulting in the activation of events re-
quired for the initiation of a sustained ETI
response. In total, the AvrPphB-initiated
ETI is sufficient to abrogate pathogen
growth and halt further infection.
Zhang and colleagues now show that,
in addition to cleavage of PBS1, AvrPphB
targets 10 PBS1-like (PBL) kinases,
including BIK1, PBL1, PBL2, and PBS1.
This is a significant finding, as it not only
implicates BIK1 and additional kinases
as potential links between multiple path-
ogen recognition events in plants, but it
also lends itself to the question: What
are the true virulence targets of AvrPphB?
Based on extensive genetic and biochem-
ical analyses, Zhang and colleagues
propose that BIK1 and possibly other
PBL kinases function to integrate immune
responses activated via multiple PAMP
receptors, such as FLS2 (Arabidopsis
flagellin receptor) (Go´mez-Go´mez and
Boller, 2000), EFR (receptor for bacterial
EF-Tu) (Zipfel et al., 2006), and CERK1
(chitin receptor) (Miya et al., 2007). The
current work demonstrates that BIK1
interacts with FLS2 in unstimulated plant
cells, is rapidly phosphorylated, and is
subsequently released from FLS2 upon
FLS2 activation by its ligand, flg22. The
ligand-dependent release of BIK1 from
FLS2 is in striking contrast to the previ-
ously described ligand-dependent com-
plex formation between FLS2 and BAK1,
a coreceptor of FLS2. Zhang et al.
proposed a model in which FLS2, BAK1,
and BIK1 form a signaling relay through010 Elsevier Inc.phosphorylation and physical interac-
tion/dissociation. Although the full mech-
anism of this interaction needs to be
worked out, this model seems to be
generally in line with that proposed
recently by Lu et al. (2010), who indepen-
dently discovered a critical role for BIK1 in
PTI signaling.
The identification of BIK1, PBS1, and
other PBL kinases as substrates of
AvrPphB, as well as the identification of
the BIK1-FLS2 association in the present
study provides strong evidence that
AvrPphB links PTI and ETI and that kinase
regulationmay be a shared feature of both
layers of defense signaling in plants. This
is an interesting finding, as it opens the
door to future work aimed at identifying
the function of other PBL kinase targets,
both in the presence and absence of
pathogen. One interesting hypothesis is
that the host has evolved multiple PBL
targets as part of a more expansive sur-
veillance mechanism. However, it is also
possible that the work described herein
has, in fact, identified the true virulence
function of AvrPphB and, as such, would
indicate that AvrPphB targets multiple
host kinases involved in PTI defense
signaling. In support of this hypothesis,
genetic data presented by Zhang et al.
suggest that the functions of BIK1,
PBL1, PBL2, and PBS1 in PTI are addi-
tive; PBS1 has a minor role in PTI,
whereas the bik1/pbl1 mutant is signifi-
cantly impaired in PTI. Though the full
details of the AvrPphB-RPS5-PBL
Cell Host & Microbe
Previewsnetwork are unknown, the current work
brings us one step closer to under-
standing the regulatory circuitry that
specifies recognition and activation of
immune signaling in plants.
Conclusions
This work provides strong evidence
bridging the gap between PTI and ETI
through the virulence function of path-
ogen effector proteins. Future work aimed
at identifying the function of PBLs, as well
as BIK1, in the absence of pathogen
infection will likely provide insight into
the evolution of host-pathogen interac-
tions, both in terms of virulence andpathogenicity, as well as conservation of
shared and/or overlapping immune
signaling pathways.
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Tetherin inhibits HIV and other enveloped viruses by grasping particles at the budding site and preventing
their release. An article by Hinz and coworkers (Hinz et al., 2010) in this issue of Cell Host & Microbe reveals
remarkable irregularities within the coiled-coil domain of the tetherin dimer that enhance flexibility of the
molecule and contribute to its function.Host restriction of viral replication can take
place at multiple points in the virus life
cycle. Tetherin (also known as BST-2/
CD317) is a cellular restriction factor best
known for its inhibition of HIV and other
retroviruses, but it also restricts arenavi-
ruses and flaviviruses (Jouvenet et al.,
2009). The wide range of viruses affected
by tetherin suggests that restriction is
unlikely to be mediated through interac-
tions with specific viral structural proteins,
but rather through interactions with other
constituents of the lipid bilayer that are en-
riched at the budding site. Tetherin is an
unusual type II membrane protein that
is anchored in the membrane by both a
transmembrane domain and a C-terminal
glycosyl-phosphatidylinositol (GPI) an-
chor. The presenceof aGPI anchor places
tetherin in lipid rafts, and it has been sug-
gested that tetherin may serve to organize
lipid rafts in the membrane, with the GPI
anchor in the lipid raft and the transmem-brane domain on the outside (Kupzig
et al., 2003). Tetherin forms homodimers
that retain particles at the budding site in
the absence of counteracting measures.
Viruses, in turn, have developed means
to overcome this restriction. The HIV-1
Vpu protein downregulates tetherin from
the cell surface and relieves tetherin-
mediated restriction, while SIV species
use Nef for overcoming tetherin’s effects
(Neil et al., 2008; Sauter et al., 2009; Zhang
et al., 2009). Electron microscopic anal-
ysis of cells infected with vpu-deficient
HIV demonstrates a remarkable pheno-
type in which arrays or clusters of virion
particles have completed budding but
remain attached to the plasmamembrane
of the cell. Tetherin is concentrated at the
particle budding site, especially at the
base of the developing particle, and is
present between strings of virions that
have completed the budding process
(Hammonds et al., 2010). The biology oftetherin and dissection of the mechanism
bywhich viruses overcome tetherin-medi-
ated restriction has been a topic of great
interest since the identification of this
restriction in 2008 (Neil et al., 2008; Van
Damme et al., 2008).
Tetherin dimers and the way in which
they hold on to virions can be modeled in
a number of ways. The molecule forms
a disulfide-linked dimer, and retention of
at least one cysteine for disulfide bonding
is required for restriction (Perez-Caballero
et al., 2009). The ectodomain includes
a coiled-coil motif that provides additional
interactions, and gross disruption of this
motif also interferes with function. An arti-
ficial form of tetherin in which the coiled-
coil motif of tetherin was replaced with
that of the dystrophia myotonica protein
kinase was able to restrict particle release
(Perez-Caballero et al., 2009). Present
models thus conclude that both disulfide
bond formation and interactions withine 7, April 22, 2010 ª2010 Elsevier Inc. 261
